1 The American College of Obstetricians and Gynecologists (ACOG) [Internet] Washington: Committee Opinion. Committee on Gynecologic Practice, American Society for Reproductive Medicine. Prepregnancy Counseling. ACOG 2019. Number 767 (reaffirmed 2020). [cited 2021, November 7]. Available from:
https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/01/prepregnancy-counseling.
2 Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al.; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep;39(34):3165-241.
3 Deutscher Bundestag, Wissenschaftliche Dienste [Internet]. Berlin: Dokumentation des wissenschaftlichen Dienstes des deutschen Bundestages, Information zu Risikoschwangerschaften und zur Pränataldiagnostik. WD 9- 3000 - 056/16. 2016. [cited 2023, April 14]. Available from:
https://www.bundestag.de/resource/blob/485814/0e49cd15133deb377c0cb1a2c1fd/wd-9-051pdf-data.pdf.
4 Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al.; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J. 2013 Jul;34(28):2159-219.
5 Davis MB, Walsh MN. Cardio-Obstetrics. Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005417.
doi: 10.1161/CIRCOUTCOMES.118.005417.
6 Ananth CV, Duzyj CM, Yadava S, Schwebel M, Tita AT, Joseph KS. Changes in the Prevalence of Chronic Hypertension in Pregnancy, United States, 1970 to 2010. Hypertension. 2019 Nov;74(5):1089-95.
doi: 10.1161/HYPERTENSIONAHA.119.12968.
7 Krieger EV, Landzberg MJ, Economy KE, Webb GD, Opotowsky AR. Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta. Am J Cardiol. 2011 May;107(10):1529-34.
doi: 10.1016/j.amjcard.2011.01.033.
8 Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019 Dec;50(47):3848-55.
doi: 10.1093/eurheartj/ehz136.
9 Mylotte D, Pilote L, Ionescu-Ittu R, Abrahamowicz M, Khairy P, Therrien J, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014 May;129(18):1804-12.
doi: 10.1161/CIRCULATIONAHA.113.005817.
10 Mehta LS, Sharma G, Creanga AA, Hameed AB, Hollier LM, Johnson JC, et al. Call to Action: Maternal Health and Saving Mothers: A Policy Statement From the American Heart Association. Circulation. 2021 Oct;144(15):e251-69.
doi: 10.1161/CIR.0000000000001000.
[11] Lu Y, Chen R, Cai J, Huang Z, Yuan H. The management of hypertension in women planning for pregnancy. Br Med Bull. 2018 Dec;128(1):75-84.
doi: 10.1093/bmb/ldy035.
12 Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita AT. Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines. Curr Hypertens Rep. 2020 Aug;22(9):66
doi: 10.1007/s11906-020-01082-w.
13 Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al.; CHIPS Study Group*. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure? Hypertension. 2016 Nov;68(5):1153-9.
doi: 10.1161/HYPERTENSIONAHA.116.07862.
14 Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012 Feb;206(2):134.el-8.
doi: 10.1016/j.ajog.2011.10.878.
15 Bornstein E, Eliner Y, Chervenak FA, Grünebaum A. Concerning trends in maternal risk factors in the United States: 1989–2018. EClinicalMedicine. 2020Nov;29-30:100657.
doi: 10.1016/j.eclinm.2020.100657.
16 Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al.; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022 May;386(19):1781-92.
doi: 10.1056/NEJMoa2201295.
17 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, Österreichische Gesellschaft für Gynäkologie und Geburtshilfe, Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe [Internet]. Berlin / Innsbruck / Sursee: Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. AWMF 015/018. S2k-Leitlinie. März 2019. Version 1.1. [cited 2023, April 14]. Available from:
https://register.awmf.org/de/leitlinien/detail/015-018
18 Magee LA, von Dadelszen P. State-of-the-Art Diagnosis and Treatment of Hypertension in Pregnancy. Mayo Clin Proc. 2018 Nov;93(11):1664-77.
doi: 10.1016/j.mayocp.2018.04.033.
19 Dodd JM, Turnbull D, McPhee AJ, Deussen AR, Grivell RM, Yelland LN, et al.; LIMIT Randomised Trial Group. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014 Feb;348:g1285.
doi: 10.1136/bmj.g1285.
20 Ponto KA, Scharrer I, Binder H, Korb C, Rosner AK, Ehlers TO, et al. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg Retinal Vein Occlusion Study. J Hypertens. 2019 Jul;37(7):1372-83.
doi: 10.1097/HJH.0000000000002057.
21 Luke B, Brown MB, Eisenberg ML, Callan C, Botting BJ, Pacey A, et al. In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters. Am J Obstet Gynecol. 2020 Apr;222(4):350.el-13.
doi: 10.1016/j.ajog.2019.10.003.
22 Gui J, Ling Z, Hou X, Fan Y, Xie K, Shen R. In vitro fertilization is associated with the onset and progression of preeclampsia. Placenta. 2020 Jan;89:50-57.
doi: 10.1016/j.placenta.2019.09.011.
23 Pettit F, Brown MA. The management of pre-eclampsia: what we think we know. Eur J Obstet Gynecol Reprod Biol. 2012 Jan;160(1):6-12.
doi: 10.1016/j.ejogrb.2011.09.049.
24 Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. BJOG. 2005 May;112(5):601-6.
doi: 10.1111/j.1471-0528.2004.00516.x.
25 Stepan H, Herraiz I, Schlembach D, Verlohren S, Brennecke S, Chantraine F, et al. Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol. 2015 Mar;45(3):241-6.
doi: 10.1002/uog.14799.
26 Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016 Jan;374(1):13-22.
doi: 10.1056/NEJMoa1414838.
27 Franz MB, Burgmann M, Neubauer A, Zeisler H, Sanani R, Gottsauner-Wolf M, et al. Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies. Acta Obstet Gynecol Scand. 2013 Aug;92(8):960-6.
doi: 10.1111/aogs.12145.
28 Pfeffer TJ, Hilfiker-Kleiner D. Pregnancy and Heart Disease: Pregnancy-Associated Hypertension and Peripartum Cardiomyopathy. Curr Probl Cardiol. 2018 Sep;43(9):364-88.
doi: 10.1016/j.cpcardiol.2017.10.005.
29 Franz M, Kainer F, Husslein PW. Physiologie des mütterlichen Organismus und Erkrankungen in der Schwangerschaft. In: Schneider H, Husslein PW, Schneider K. (eds) Die Geburtshilfe. Springer Reference Medizin. Springer, Berlin, Heidelberg; 2015.
30 Capeless EL, Clapp JF. When do cardiovascular parameters return to their preconception values? Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):883-6.
doi: 10.1016/0002-9378(91)90432-Q.
31 Schneider H, Raio L, Pollheimer J, Knöfler M. Präimplantation, Implantation und Plazentation. In: Schneider H, Husslein PW, Schneider KT, editors. Die Geburtshilfe. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015. Pp. 1-24.
doi: 10.1007/978-3-662-44369-9_1-1.
32 The Fetal Medicine Foundation [Internet]. London: Education. Preeclampsia screening; c2023. [cited 2023, April 14]. Available from:
https://fetalmedicine.org/education/preeclampsia-screening.
33 Brosens I, Puttemans P, Benagiano G. Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes. Am J Obstet Gynecol. 2019 Nov;221(5):437-56.
doi: 10.1016/j.ajog.2019.05.044.
34 Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003 Mar;111(5):649-58
doi: 10.1172/JCI17189.
35 Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012 May;485(7398):333-8.
doi: 10.1038/nature11040.
36 Thakkar A, Hailu T, Blumenthal RS, Martin SS, Harrington CM, Yeh Dd, et al. Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention. Curr Atheroscler Rep. 2022 Jul;24(7):493-507.
doi: 10.1007/s11883-022-01026-6.
37 Morgan TK. Role of the Placenta in Preterm Birth: A Review. Am J Perinatol. 2016 Feb;33(3):258-66.
doi: 10.1055/s-0035-1570379.
38 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009 Jun;33(3):130-7.
doi: 10.1053/j.semperi.2009.02.010.
39 Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8-15.
doi: 10.1159/000341264.
40 Gäckler A, Witzke O. Thrombotische Mikroangiopathie: Diagnose und Therapie [Thrombotic microangiopathy]. Nephrologe. 2021;16(2):113-23. German.
doi: 10.1007/s11560-021-00487-1.
41 Fakhouri F, Frémeaux-Bacchi V. Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics. Nat Rev Nephrol. 2021 Aug;17(8):543-53.
doi: 10.1038/s41581-021-00424-4.
42 Abou-Dakn M. Mikroangiopathien in der Schwangerschaft. Gynäkologie. 2022 Aug;55(8):559-66.
doi: 10.1007/s00129-022-04972-z.
43 Lingner M, Majolk J, Niederer O. Geburtshilfe: die peripartale Kardiomyopathie. Anästhesiol Intensivmed Notfallmed Schmerzther. 2017 Mar;52(3):196-203.
doi: 10.1055/s-0042-101049.
44 Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell. 2007 Feb;128(3):589-600.
doi: 10.1016/j.cell.2006.12.036.
45 Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy. J Am Coll Cardiol. 2013 Oct;62(18):1715-1723.
doi: 10.1016/j.jacc.2013.08.717.
46 Bauersachs J, König T, van der Meer P, Petrie MC, Hilfiker-Kleiner D, Mbakwem A, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019 Jul;21(7):827-43.
doi: 10.1002/ejhf.1493.
47 Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker-Kleiner D. Peripartum cardiomyopathy: from genetics to management. Eur Heart J. 2021 Aug;42(32):3094-102.
doi: 10.1093/eurheartj/ehab458.
48 Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013 Jul;108(4):366.
doi: 10.1007/s00395-013-0366-9.
49 Ricke-Hoch M, Pfeffer TJ, Hilfiker-Kleiner D. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies. Cardiovasc Res. 2020 Mar;116(3):520-31. doi: 10.1093/cvr/cvz252.
50 Mebazaa A, Seronde MF, Gayat E, Tibazarwa K, Anumba DO, Akrout N, et al. Imbalanced Angiogenesis in Peripartum Cardiomyopathy – Diagnostic Value of Placenta Growth Factor. Circ J. 2017 Oct;81(11):1654-61.
doi: 10.1253/circj.CJ-16-1193.
51 Barut F, Barut A, Gun BD, Kandemir NO, Harma MI, Aktunc E, et al. Intrauterine growth restriction and placental angiogenesis. Diagn Pathol. 2010 Apr;5(1):24.
doi: 10.1186/1746-1596-5-24.
52 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, Österreichische Gesellschaft für Gynäkologie und Geburtshilfe, Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe [Internet]. Berlin / Innsbruck / Sursee: Prävention und Therapie der Frühgeburt. AWMF 015-025. S2k-Leitlinie. September 2022. Version 5.0. [cited 2023 April 14]. Available from:
https://register.awmf.org/assets/guidelines/015-025l_S2k_Praevention-Therapie-Fruehgeburt_2022-09.pdf.
53 Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):e003497
doi: 10.1161/CIRCOUTCOMES.116.003497.
54 Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014 Apr;348:g2301.
doi: 10.1136/bmj.g2301.
55 Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynecol. 2008;1(4):170-8.
56 The American College of Obstetricians and Gynecologists (ACOG) [Internet]. Washington: Exercise during pregnancy. Frequently Asked Questions; c2019 [cited 2021 Nov 23]. Available from:
https://www.acog.org/womens-health/faqs/exercise-during-pregnancy.
57 Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al.; US Preventive Services Task Force. Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 May;325(20):2087-93.
doi: 10.1001/jama.2021.6949.
58 Redman CW. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976 Oct;2(7989):753-6.
doi: 10.1016/S0140-6736(76)90597-3.
59 Cockburn J, Moar VA, Ounsted M, Redman CW. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet. 1982 Mar;1(8273):647-9.
doi: 10.1016/S0140-6736(82)92202-4.
60 Clark SM, Dunn HE, Hankins GD. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. Semin Perinatol. 2015 Nov;39(7):548-55.
doi: 10.1053/j.semperi.2015.08.011.
61 Shekhar S, Gupta N, Kirubakaran R, Pareek P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG. 2016 Jan;123(1):40-7.
doi: 10.1111/1471-0528.13463.
62 Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun;135(6):e237-60.
doi: 10.1097/AOG.0000000000003891.
63 Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003 Oct;327(7421):955-60.
doi: 10.1136/bmj.327.7421.955.
64 Vigil-De Gracia P, Lasso M, Ruiz E, Vega-Malek JC, de Mena FT, López JC; or the HYLA treatment study. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):157-62.
doi: 10.1016/j.ejogrb.2006.02.015.
65 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, Österreichische Gesellschaft für Gynäkologie und Geburtshilfe, Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe [Internet]. Berlin / Innsbruck / Sursee: Geburtseinleitung. AWMF 015-088. S2k-Leitlinie. Dezember 2020. Version 1.1. [cited 2023, April 14]. Available from:
https://www.awmf.org/leitlinien/detail/ll/015-088.html.
66 Ram M, Berger H, Geary M, McDonald SD, Murray-Davis B, Riddell C, et al.; Diabeted, Obesity and Hypertension in Pregnancy Research Network (DOH-NET) and the Southern Ontario Obstetrical Network (SOON) Investigators. Timing of Delivery in Women With Chronic Hypertension. Obstet Gynecol. 2018 Sep;132(3):669-77.
doi: 10.1097/AOG.0000000000002800.
67 Venkatesh KK, Strauss RA, Westreich DJ, Thorp JM, Stamilio DM, Grantz KL. Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity. Pregnancy Hypertens. 2020 Apr;20:75-82.
doi: 10.1016/j.preghy.2020.03.006.
68 Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, et al.; HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015 Jun;358(9986):2492-501.
doi: 10.1016/S0140-6736(14)61998-X.
69 When do obstetricians recommend delivery for a high-risk preterm growth-retarded fetus? The GRIT Study Group. Growth Restriction Intervention Trial. Eur J Obstet Gynecol Reprod Biol. 1996 Aug;67(2):121-6.
doi: 10.1016/0301-2115(96)02448-7.
70 Duley L,Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2003;(4):CD000128.
doi: 10.1002/14651858.CD000128. Update in: Cochrane Database Syst Rev. 2010;(10):CD000128. PMID: 14583911.
71 Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun;135(6):e237-60.
doi: 10.1097/AOG.0000000000003891.
72 Fakhouri F, Scully M, Ardissino G, Al-Dakkak I, Miller B, Rondeau E. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis. J Nephrol. 2021 Oct;34(5):1581-90.
doi: 10.1007/s40620-021-01025-x.
73 Ouzounian JG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin. 2012 Aug;30(3):317-29.
doi: 10.1016/j.ccl.2012.05.004.
74 Mehta LS, Warners CA, Bradley E, Burton T, Economy K, Mehran R, et al.; American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Stroke Council. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association. Circulation. 2020 Jun;141(23):e884-903.
doi: 10.1161/CIR.0000000000000772.
75 The American College of Obstetricians and Gynecologists (ACOG) [Internet]. Washington DC: ACOG Committee Opinion. Presidential Task Force on Redefining the Postpartum Visit; Committee on Obstetric Practice. Optimizing Postpartum Care. 2018 May. Number 736. [cited 2021 Nov 6]. Available from:
https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2018/05/optimizing-postpartum-care .
76 Dathe K, Schaefer C. The Use of Medication in Pregnancy. Dtsch Arztebl Int. 2019 Nov;116(46):783-90.
doi: 10.3238/arztebl.2019.0783.
77 Sharma G, Ying W, Silversides CK. The Importance of Cardiovascular Risk Assessment and Pregnancy Heart Team in the Management of Cardiovascular Disease in Pregnancy. Cardiol Clin. 2021 Feb;39(1):7-19.
doi: 10.1016/j.ccl.2020.09.002.
78 Jones EJ, Hernandez TL, Edmonds JK, Ferranti EP. Continued Disparities in Postpartum Follow-Up and Screening Among Women With Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Systematic Review. J Perinat Neonatal Nurs. 2019;33(2):136-48.
doi: 10.1097/JPN.0000000000000399.
79 Cameron NA, Molsberry R, Pierce JB, Perak AM, Grobman WA, Allen NB, eta al. Pre-Pregnancy Hypertension Among Women in Rural and Urban Areas of the United States. J Am Coll Cardiol. 2020 Dec;76(22):2611-2619.
doi: 10.1016/j.jacc.2020.09.601.
80 DeNicola N, Grossman D, Marko K, Sonalkar S, Butler Tobah YS, Ganju N, et al. Telehealth Interventions to Improve Obstetric and Gynecologic Health Outcomes: A Systematic Review. Obstet Gynecol. 2020 Feb;135(2):371-82.
doi: 10.1097/AOG.0000000000003646.
81 De Schepper S, Vercauteren T, Tersago J, Jacquemyn Y, Raes F, Franck E. Post-Traumatic Stress Disorder after childbirth and the influence of maternity team care during labour and birth: A cohort study. Midwifery. 2016 Jan;32:87-92.
doi: 10.1016/j.midw.2015.08.010.
82 Simpson M, Schmied V, Dickson C, Dahlen HG. Postnatal post-traumatic stress: An integrative review. Women Birth. 2018 Oct;31(5):367-79.
doi: 10.1016/j.wombi.2017.12.003.
83 O’Higgins AC, O’Dwyer V, O’Connor C, Daly SF, Kinsley BT, Turner MJ. Postpartum dyslipidaemia in women diagnosed with gestational diabetes mellitus. Ir J Med Sci. 2017 May;186(2):403-7.
doi: 10.1007/s11845-016-1474-y.
84 Jowell AR, Sarma AA, Gulati M, Michos ED, Vaught AJ, Natarajan P, et al. Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes: A Review. JAMA Cardiol. 2022 Mar;7(3):346-55.
doi: 10.1001/jamacardio.2021.4391.
85 Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007 Nov;335(7627):974.
doi: 10.1136/bmj.39335.385301.BE.
86 Black MH, Zhou H, Sacks DA, Dublin S, Lawrence JM, Harrison TN, et al. Hypertensive disorders first identified in pregnancy increase risk for incident prehypertension and hypertension in the year after delivery. J Hypertens. 2016 Apr;34(4):728-35.
doi: 10.1097/HJH.0000000000000855.
87 Theilen LH, Fraser A, Hollingshaus MS, Schliep KC, Varner MW, Smith KR, et al. All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. Obstet Gynecol. 2016 Aug;128(2):238-44.
doi: 10.1097/AOG.0000000000001534.
88 Parikh NI, Gonzalez JM, Anderson CA, Judd SE, Rexrode KM, Hlatky MA, et al.; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; the Stroke Council. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021 May;143(18):e902-16.
doi: 10.1161/CIR.0000000000000961.
89 Caropreso L, de Azevedo Cardoso T, Eltayebani M, Frey BN. Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Arch Women Ment Health. 2020 Aug;23(4):493-505.
doi: 10.1007/s00737-019-01010-1.
90 O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol. 2016 Jan;214(1):103.el-12.
doi: 10.1016/j.ajog.2015.08.034.
91 Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017 Aug;377(7):613-22.
doi: 10.1056/NEJMoa1704559.